Tailoring apixaban in nanostructured lipid carrier enhancing its oral bioavailability and anticoagulant activity

HIGHLIGHTS

  • who: Mohamed F. Zaky and colleagues from the Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Egyptian Russian University have published the article: Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity, in the Journal: Pharmaceutics 2023, 15, x FOR PEERFigure REVIEW 11 of 22 2. Standardized Pareto charts showing the effects of the investigated factors on all responses of /2023/
  • what: The aim of this study was to improve the formulation of an Apx-loaded nanostructured lipid (NLC) to increase and effectiveness. The study was performed to test the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?